Predilife
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer pred… Read more
Market Cap & Net Worth: Predilife (ALPRE)
Predilife (PA:ALPRE) has a market capitalization of $12.83 Million (€12.50 Million) as of March 18, 2026. Listed on the PA stock exchange, this France-based company holds position #32741 globally and #373 in its home market, demonstrating a 1.59% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Predilife's stock price €3.19 by its total outstanding shares 3919498 (3.92 Million).
Predilife Market Cap History: 2018 to 2026
Predilife's market capitalization history from 2018 to 2026. Data shows change from $37.62 Million to $12.83 Million (-13.74% CAGR).
Predilife Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Predilife's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
23.43x
Predilife's market cap is 23.43 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
0.07x
Predilife's market cap is 0.07 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $37.62 Million | $72.26K | -$2.37 Million | 520.60x | N/A |
| 2019 | $31.98 Million | $22.87K | -$2.10 Million | 1398.43x | N/A |
| 2020 | $29.17 Million | $51.57K | -$2.25 Million | 565.60x | N/A |
| 2021 | $27.76 Million | $142.08K | -$3.41 Million | 195.38x | N/A |
| 2022 | $21.40 Million | $288.60K | -$3.65 Million | 74.16x | N/A |
| 2023 | $22.93 Million | $317.79K | -$4.22 Million | 72.16x | N/A |
| 2024 | $14.48 Million | $618.06K | $198.63 Million | 23.43x | 0.07x |
Competitor Companies of ALPRE by Market Capitalization
Companies near Predilife in the global market cap rankings as of March 18, 2026.
Key companies related to Predilife by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Predilife Historical Marketcap From 2018 to 2026
Between 2018 and today, Predilife's market cap moved from $37.62 Million to $ 12.83 Million, with a yearly change of -13.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €12.83 Million | +5.98% |
| 2025 | €12.11 Million | -16.39% |
| 2024 | €14.48 Million | -36.84% |
| 2023 | €22.93 Million | +7.14% |
| 2022 | €21.40 Million | -22.90% |
| 2021 | €27.76 Million | -4.83% |
| 2020 | €29.17 Million | -8.81% |
| 2019 | €31.98 Million | -14.97% |
| 2018 | €37.62 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Predilife was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.83 Million USD |
| MoneyControl | $12.83 Million USD |
| MarketWatch | $12.83 Million USD |
| marketcap.company | $12.83 Million USD |
| Reuters | $12.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.